Skip to main content

Stratagene Shares Continue Rebound as Index Falls

Shares of Stratagene gained 9.5 percent to lead all stocks in the BCW Index for the trading week ended Tuesday. The firm's shares have risen 27 percent since hitting a 52-week low on June 27. Stratagene was only one of four companies in the Index to gain ground for the tracking period. Invitrogen and Agilent led the decliners for the week, falling 5.6 percent and 5.3 percent, respectively.

Overall, the Index dropped 1.3 percent. In comparison, the Dow Jones Industrial Average declined .8 percent, the Nasdaq dropped 2.8 percent, and the Nasdaq Biotech Index fell 1.6 percent.

BioCommerce Week Index of Diversified Molecular Biology Tool Companies
Company
Ticker
Current Price
(July 11, 2006)
Last Price
(July 3, 2006)
% change
Agilent
A
30.18
31.86
-5.3
Applied Biosystems
ABI
32.70
32.84
-0.4
Beckman
BEC
56.44
55.89
1.0
Bio-Rad
BIO
65.54
65.55
0.0
Bruker
BRKR
5.46
5.29
3.2
Fisher Scientific
FSH
71.38
73.68
-3.1
GE
GE
33.26
33.33
-0.2
Invitrogen
IVGN
62.37
66.10
-5.6
Millipore
MIL
62.61
62.25
0.6
Molecular Devices
MDCC
30.15
30.21
-0.2
PerkinElmer
PKI
21.11
21.27
-0.8
Qiagen
QGEN
13.52
13.74
-1.6
Sigma
SIAL
71.79
72.59
-1.1
Stratagene
STGN
7.00
6.39
9.5
Thermo
TMO
35.55
36.42
-2.4
Waters
WAT
44.04
44.48
-1.0
BCW Index Average
40.19
40.74
-1.3
The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.